Mike Crapo said...

NACDS appreciates the Committee's work to explore PBMs' lack of transparency and standardized performance measures.

When we talk about the need for greater transparency in the drug supply chain, that term can and should mean a few diffe...

I have long championed efforts to improve prescription drug access and affordability for all Americans.

We need to identify avenues for lowering out-of-pocket costs, increasing competition, and promoting access to lifesaving...